1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Langyan Life

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2010

Location

Beijing China

Primary Industry

Biotechnology

About

Based in Beijing, China and established in 2010, BLangyan Life is a pharmaceutical company that focuses on the research and development of chemical preparations and APIs. In 2022, the company was acquired by Beijing Sun-Novo Pharmaceutical Research Co.,Ltd. The company's main products include valsartan hydrochlorothiazide tablets, valsartan amlodipine tablets (I), lumbrokinase enteric coated capsules, entecavir tablets, ivabradine hydrochloride tablets, SOPHOBUVIR APIs, aminocaproic acid APIs, etc. Its products are used in cardiovascular diseases, endocrine system diseases and digestive system diseases. Langyan Life also provides external pharmaceutical production services.
Current Investors
Kaitai Capital, GF Xinde Investment, Wisdomont Capital

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development, Medicinal Chemicals & Botanicals
Company Stage
Add-on
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo